Neurologic complications of immunization

Journal of Child Neurology

Volumn 19, Issue 6, 2004, Pages 405-412

  Bale Jr , James F ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DRUG PRESERVATIVE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MERCURY; ORAL POLIOMYELITIS VACCINE; RABIES VACCINE; THIOMERSAL;

ACTIVE IMMUNIZATION; ANOREXIA; ATTENTION DEFICIT DISORDER; AUTISM; BORDETELLA PERTUSSIS; BRAIN DISEASE; CHICKENPOX; CHILD; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; DEVELOPED COUNTRY; DIPHTHERIA; DISEASE ASSOCIATION; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG FATALITY; ENCEPHALITIS; ERYTHEMA; FEVER; GASTROINTESTINAL DISEASE; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE TYPE B; HEADACHE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INFANTILE SPASM; INFLUENZA; INJECTION PAIN; INJECTION SITE; LANGUAGE DISABILITY; MEASLES; MEASLES VIRUS; MINAMATA DISEASE; MULTIPLE SCLEROSIS; MYALGIA; NEUROLOGIC DISEASE; PERTUSSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVIEW; RUBELLA; RUBELLA VIRUS; SEIZURE; SHOCK; SOMNOLENCE; SPEECH DISORDER; SUDDEN INFANT DEATH SYNDROME; TETANUS; UNITED STATES; VARICELLA ZOSTER VIRUS;

EID: 4544292849     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380401900602     Document Type: Review

References (49)

1. American Academy of Pediatrics: 2003 Red Book: Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL, American Academy of Pediatrics, 2003.
2. Pascual FB, McGinley EL, Zanardi LR, et al: Tetanus surveillance - United States 1998-2000. MMWR Morb Mortal Wkly Rep 2003;52:1-8.
3. Cherry JD, Brunell PA, Golden GS, Karzon DT: Report of the task force on pertussis and pertussis immunization-1988. Pediatrics 1988;81(Suppl):939-984.
4. Centers for Disease Control and Prevention: Pertussis. MMWR Morb Mortal Wkly Rep 1987;36:168-171.
5. Golden GS: Pertussis vaccine and injury to the brain. J Pediatr 1990;116:854-861.
6. Barlow WE, Davis RL, Glasser JW, et al: The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccines. N Engl J Med 2001;345:656-661.
7. Hirtz DG, Nelson KB, Ellenberg JH: Seizures following childhood immunizations. J Pediatr 1983;102:14-18.
8. Miller DL, Ross EM, Alderslade R, et al: Pertussis immunisation and serious acute neurologic illness in children. BMJ 1981;282:1595-1599.
9. Bellman MH, Ross EM, Miller DL: Infantile spasms and pertussis immunisation. Lancet 1983;i:1031-1033.
10. Fenichel GM: Assessment: Neurologic risk of immunization. Neurology 1999;52:1546-1552.
11. Hamati-Hadda A, Fenichel GM: Brachial neuritis following routine childhood immunization for diphtheria, tetanus, and pertusis (DTP): Report of two cases and review of the literature. Pediatrics 1997;99:602-603.
12. Holliday PL, Bauer RB: Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Arch Neurol 1983;40:56-57.
13. Reinstein L, Pargament JM, Goodman JS: Peripheral neuropathy after multiple tetanus toxoid injections. Arch Phys Med Rehabil 1982;63:332-334.
14. Bale JF Jr: Encephalitis and other virus-induced disorders of the nervous system, in Joynt RJ, Griggs RC (eds): Clinical Neurology. Philadelphia, Lippincott-Raven, 1996, 1-56.
15. Zilber N, Rannon L, Alter M, et al: Measles, measles vaccination and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983;33:1558-1564.
16. Murphy JV, Yunis EJ: Encephalopathy following measles infection in children with chronic illness. J Pediatr 1976;88:937-942.
17. Aicardi J, Goutieres F, Arsenio-Nunes ML, et al: Acute measles encephalitis in children with immunosuppression. Pediatrics 1977;59:232-239.
18. Mustafa MM, Weitman SD, Winick NJ, et al: Subacute measles encephalitis in the young immunocompromised host: Report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993;16:654-660.
19. Wakefield AJ, Murch SH, Anthony A, et al: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-641.
20. Fombonne E, Chakrabarti S: No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001;108:E58.
21. Kaye JA, del Mar Melero-Montes M, Jick H: Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ 2001;322:460-463.
22. Halsey NA, Hyman SL, Conference Writing Panel: Measles-mumps-rubella vaccine and autistic spectrum disorder: Report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics 2001;107:E84.
23. Dales L, Hammer SJ, Smith NJ: Time trends in autism and in MMR immunization coverage in California. JAMA 2001;285: 1183-1185.
24. Institute of Medicine: Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC, National Academy Press, 2001.
25. Ogra PL, Faden HS: Poliovirus vaccines: Live or dead. J Pediatr 1986;108:1031-1033.
26. Nkowane BM, Wassilak SGR, Orenstein WA, et al: Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 1987;257:1335-1340.
27. Centers for Disease Control and Prevention: Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-3):1-25.
28. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al: Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979;110:105-123.
29. Schoneberger LB, Hurwitz ES, Katona F, et al: Guillain-Barré syndrome: Its epidemiology and associations with influenza vaccination. Ann Neurol 1981;9(Suppl):31-38.
30. Lasky T, Terrcciano GJ, Magder L, et al: The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998;339:1797-1802.
31. Saito H, Endo M, Takase S, et al: Acute disseminated encephalomyelitis after influenza vaccination. Arch Neurol 1980;37:564-566.
32. Hemachudha T, Phanuphak P, Johnson RT, et al: Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies. Neurology 1987;37:550-556.
33. Boe E, Nyland H: Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis 1980; 12:231-232.
34. Gout O: Vaccinations and multiple sclerosis. Neurol Sci 2001;22:151-154.
35. Tourbah A, Gout O, Liblau R, et al: Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS? Neurology 1999;53:396-401.
36. Monteyne P, Andre FE: Is there a causal link between hepatitis B vaccination and multiple sclerosis? Vaccine 2000;18:1994-2001.
37. Tosti ME, Traversa G, Bianco E, Mele A: Multiple sclerosis and vaccination against hepatitis B: Analysis of risk benefit profile. Ital J Gastroenterol Hepatol 1999;31:388-391.
38. Ascherio A, Zhang SM, Hernan MA, et al: Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001;344:327-332.
39. Sinsawaiwong S, Thampanitchawong P: Guillain-Barre syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai 2000;83:1124-1126.
40. Takahashi M: 25 years' experience with the Biken Oka strain varicella vaccine: A clinical overview. Pediatr Drugs 2001;3:285-292.
41. Sunaga Y, Hikima A, Ostuka T, Morikawa A: Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol 1995;13:340-342.
42. Gail K, Lee B, Strine T, et al: Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-1915.
43. Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR Morb Mortal Wkly Rep 1999;9:563-565.
44. Tokuomi H, Okajima T, Kanai J, et al: Minamata disease. World Neurol 1961;2:536-545.
45. Additional information regarding thimerosal can be found at: http://www.fda.gov/cber/vaccine/thimerosal.htm.
46. Bernard S, Enayati A, Redwood L, et al: Autism: A novel form of mercury poisoning. Med Hypotheses 2001;56:462-471.
47. Ball LK, Ball R, Pratt RD: An assessment of thimerosal use in childhood vaccines. Pediatrics 2001;107:1147-1154.
48. Institute of Medicine: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC, National Academy Press, 2001.
49. Madsen KM, Lauritsen MB, Pedersen CB, et al: Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 2003;112:604-606.